Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 14,100.00p on 25-11-2025 at 19:35:13
Change 166.00p 1.19%
Buy 14,106.00p
Sell 14,102.00p
Last Trade: Buy 460.00 at 13,884.00p
Day's Volume: 2,168,716
Last Close: 14,100.00p
Open: 13,874.00p
ISIN: GB0009895292
Day's Range 13,852.00p - 14,140.00p
52wk Range: 9,574.00p - 14,140.00p
Market Capitalisation: £218.59b
VWAP: 13,996.18199p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 460 13,884.00p SI Trade
18:47:12 - 25-Nov-25
Buy* 28 14,100.00p SI Trade
Negotiated Trade
16:49:04 - 25-Nov-25
Buy* 1,182 14,100.00p SI Trade
Negotiated Trade
16:49:04 - 25-Nov-25
Sell* 3,248 14,085.498p SI Trade
16:43:54 - 25-Nov-25
Sell* 1,000 14,100.00p Automatic Execution
16:37:20 - 25-Nov-25
Sell* 947 14,100.00p Automatic Execution
16:37:19 - 25-Nov-25
Buy* 53 14,100.00p Automatic Execution
16:37:19 - 25-Nov-25
Buy* 500 14,100.00p Automatic Execution
16:36:48 - 25-Nov-25
Sell* 996 14,100.00p Automatic Execution
16:36:12 - 25-Nov-25
Buy* 4 14,100.00p Automatic Execution
16:36:12 - 25-Nov-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Nov 2025 (Tue) 13,874.00 14,140.00 13,852.00 14,100.00 2,168,716
24th Nov 2025 (Mon) 13,932.00 13,970.00 13,820.00 13,934.00 3,131,310
21st Nov 2025 (Fri) 13,508.00 13,836.00 13,508.00 13,820.00 3,044,642
20th Nov 2025 (Thu) 13,604.00 13,788.00 13,600.00 13,650.00 1,656,417
19th Nov 2025 (Wed) 13,560.00 13,742.00 13,506.00 13,596.00 1,594,092
18th Nov 2025 (Tue) 13,800.00 13,884.00 13,466.00 13,566.00 1,654,390
17th Nov 2025 (Mon) 13,530.00 13,658.00 13,520.00 13,592.00 1,324,376
14th Nov 2025 (Fri) 13,464.00 13,574.00 13,408.00 13,532.00 1,347,776
13th Nov 2025 (Thu) 13,440.00 13,506.00 13,320.00 13,494.00 1,534,952
12th Nov 2025 (Wed) 13,548.00 13,548.00 13,390.00 13,518.00 1,841,563
11th Nov 2025 (Tue) 13,400.00 13,508.00 13,286.00 13,466.00 2,222,864
10th Nov 2025 (Mon) 12,904.00 13,206.00 12,840.00 13,126.00 3,313,114
7th Nov 2025 (Fri) 12,788.00 12,938.00 12,714.00 12,900.00 3,536,318
6th Nov 2025 (Thu) 12,570.00 12,994.00 12,330.00 12,834.00 3,100,521
5th Nov 2025 (Wed) 12,528.00 12,596.00 12,436.00 12,450.00 1,818,390
4th Nov 2025 (Tue) 12,448.00 12,528.00 12,242.00 12,528.00 1,233,294
3rd Nov 2025 (Mon) 12,546.00 12,584.00 12,352.00 12,364.00 1,847,968
31st Oct 2025 (Fri) 12,562.00 12,584.00 12,424.00 12,470.00 1,088,828
30th Oct 2025 (Thu) 12,456.00 12,556.00 12,366.00 12,546.00 1,214,406
29th Oct 2025 (Wed) 12,500.00 12,684.00 12,424.00 12,560.00 946,472
28th Oct 2025 (Tue) 12,586.00 12,708.00 12,406.00 12,406.00 1,501,103
27th Oct 2025 (Mon) 12,530.00 12,616.00 12,446.00 12,546.00 1,464,674
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
24th Nov 2025 7:00 am RNS AstraZeneca manufacturing investment in Maryland
20th Nov 2025 7:00 am RNS Koselugo (selumetinib) approved in the US
17th Nov 2025 3:00 pm RNS Holding(s) in Company
14th Nov 2025 11:00 am RNS Director/PDMR Shareholding
10th Nov 2025 3:00 pm RNS Director/PDMR Shareholding
6th Nov 2025 7:00 am RNS 9M and Q3 2025 results
3rd Nov 2025 4:00 pm RNS Result of General Meeting
3rd Nov 2025 3:00 pm RNS Total Voting Rights
28th Oct 2025 7:05 am RNS Director Declaration
28th Oct 2025 7:00 am RNS Koselugo (selumetinib) approved in the EU
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca's Imfinzi wins US approval for gastroesophageal cancer

25th Nov 2025 20:18

(Alliance News) - AstraZeneca PLC on Tuesday said Imfinzi has been approved in the US as the first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers. Read More

AstraZeneca unveils USD2 billion manufacturing investment in Maryland

21st Nov 2025 21:59

(Alliance News) - AstraZeneca PLC on Friday announced plans to invest USD2 billion to expand its long-standing manufacturing footprint in Maryland. Read More

AstraZeneca gets US approval for Koselugo for rare genetic disorder

20th Nov 2025 09:06

(Alliance News) - AstraZeneca PLC on Thursday said US regulators have approved its drug Koselugo for use in adults with neurofibromatosis type 1, expanding access to a treatment already used in children with the rare genetic condition. Read More

LONDON MARKET OPEN: Stocks sold off on lingering tech worry

18th Nov 2025 08:45

(Alliance News) - Stock prices in Europe opened in the red on Tuesday, following sharp falls in Asia and as equities in New York struggled overnight, with the S&P 500 ending below a key level for the first time a number of months. Read More

LONDON MARKET CLOSE: Stocks hit, bond yields jump amid tax U-turn talk

14th Nov 2025 17:03

(Alliance News) - Stocks fell and bonds yields spiked in volatile trading on Friday amid uncertainty over UK budget proposals after an apparent u-turn on tax policy by Chancellor Rachel Reeves. Read More

See more Astrazeneca news
FTSE 100 Latest
Value9,609.53
Change74.62

Login to your account

Forgot Password?

Not Registered